The Metabolic Syndrome in Cancer Survivors
Metabolic Syndrome in Cancer Survivors
EC de Haas, SF Oosting, JD Lefrandt, BHR Wolffenbuttel, DT Sleijfer, JA Gietema
Yes
20100101
2010 Feb 1
Lancet Oncol
The Metabolic Syndrome in Cancer Survivors
Lancet Oncol. 2010 Feb 1;11(2):193-203, EC de Haas, SF Oosting, JD Lefrandt, BHR Wolffenbuttel, DT Sleijfer, JA Gietema
Abstract
Abstract
The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an important connection between cancer treatment and its common late effect of cardiovascular disease. Insight into the aetiology of the metabolic syndrome after cancer treatment might help to identify and treat cancer survivors with increased cardiovascular risk. In this review, we summarise current knowledge on the prevalence and pathophysiology of the metabolic syndrome in cancer survivors, and discuss current intervention...
